Incyte (INCY) Stock Price, Quote, News & History | Benzinga

Incyte Corp (INCY) Stock Price, Quote, News & History

INCYNASDAQ

Trade with Public

Trade with Public

$97.41

0.330.34%

At close: May 20, 5:00 PM EST

$97.41

0.330.34%

Pre-Market: 4:00 AM EST

OverviewNews Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

-

Close

$97.41

Volume / Avg.

5.00 / 1.50M

Day Range

- - -

52 Wk Range

63.51 - 112.29

Market Cap

$19.46B

P/E Ratio

13.76

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

7.96%

Days to Cover

7.05

Recent Incyte Corp News

Tempus AI Stock Soars After Posting Triple-Digit Diagnostics Growth

Tempus AI (NASDAQ: TEM) stock rose after releasing preliminary Q4 and 2025 results, with revenue of $1.27B in 2025 and $367M in Q4.

Lekha Gupta

Incyte Study Shows Lymphoma Drug Combo Slows Aggressive Blood Cancer

Incyte reported positive results from a trial of tafasitamab as a first-line treatment for adults with DLBCL. No new safety issues were seen.

Vandana Singh

Incyte's New Therapy Shows Signs Of 'Disease-Modifying' Potential In Rare Blood Cancer

Early ASH 2025 data shows Incyte's INCA033989 delivers spleen, anemia and symptom improvements in mutCALR myelofibrosis.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

1.52B

Investing Cash Flow (TTM)

-191.91M

Financing Cash Flow (TTM)

198.54M

Free Cash Flow (TTM)

1.42B

Capital Expenditure (TTM)

-95.90M

Net Change in Cash (TTM)

1.52B

Analyst Trends and Forecast

1

2

Jan

6

1

Feb

3

1

Mar

2

Apr

2

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.7

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$15.48B

PE Ratio (TTM)

13.76

PE Ratio (FWD)

12.66

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.69

PB Ratio (TTM)

3.46

Earnings Yield % (TTM)

7.27%

Earnings Yield % (FWD)

7.90%

EV / EBITDA (TTM)

8.28

Price / EBITDA (TTM)

10.56

Price / Free Cash Flow (TTM)

13.91

Book Value / Share

$28.14

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$4.64M

Total Cash

$3.46B

Debt to Equity

0.01

Issuance of Debt (TTM)

-$4.64M

Repayment of Debt (TTM)

-$4.64M

Key Statistics

Open

-

Close

$97.41

Volume / Avg.

5.00 / 1.50M

Day Range

- - -

52 Wk Range

63.51 - 112.29

Market Cap

$19.46B

P/E Ratio

13.76

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

7.96%

Days to Cover

7.05

About

Sector

Health Care

Industry

Biotechnology

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheuma...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Incyte (INCY) stock?

A

You can purchase shares of Incyte (NASDAQ:INCY) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Incyte (INCY) competitors?

A

There are no as such competitors for Incyte.

Q

What is the forecast, or price target, for Incyte (INCY) stock?

A

Incyte has a consensus price target of $97.40.

Q

What is the current price for Incyte (INCY)?

A

The stock price for Incyte (NASDAQ: INCY) is $97.41 last updated May 21, 2026 at 4:00 PM EDT.

Q

Does Incyte (INCY) pay a dividend?

A

There are no upcoming dividends for Incyte.

Q

When is Incyte (NASDAQ:INCY) reporting earnings?

A

Incyte does not have any upcoming earnings scheduled.

Q

Is Incyte (INCY) going to split?

A

There is no upcoming split for Incyte.

Q

What sector and industry does Incyte (INCY) operate in?

A

Incyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.